Article
GCM2 p.Tyr394Ser variant in Ashkenazi Israeli patients with suspected familial isolated hyperparathyroidism.
Frontiers in endocrinology - 1 Jan 2023
Szalat Auryan, Shpitzen Shoshana, Pollack Rena, Mazeh Haggi, Durst Ronen, Meiner Vardiella
Abstract excerpt
Context: A germline mutation can be identified in up to 10% of patients with primary hyperparathyroidism (PHPT). In 2017, a high frequency of the GCM2 [(NM_ 004752.4) c.1181A> C; p.Tyr394Ser; rs142287570] variant was reported in PHPT Ashkenazi Jews (AJ). Objective: To evaluate the presence of the GCM2 p.Tyr394Ser variant in Israeli patients addressed for genetic evaluation to characterize their phenotype and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
